Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The hemolytic uremic syndrome

R L Siegler1

  • 1Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, USA.

Pediatric Clinics of North America
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Hemolytic uremic syndrome (HUS) is a leading cause of acute kidney failure in children, often following E. coli O157:H7 infections. Public health measures reduce HUS, but further research is needed for effective treatments and understanding rare forms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clustering of post-diarrheal (Shiga toxin-mediated) hemolytic uremic syndrome in families.

Clinical nephrology·2003
Same author

Response to Shiga toxin-1, with and without lipopolysaccharide, in a primate model of hemolytic uremic syndrome.

American journal of nephrology·2001
Same author

Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1.

The American journal of pathology·1999
Same author

Hemolytic-uremic syndrome in adolescents.

Archives of pediatrics & adolescent medicine·1997
Same author

Acute renal failure in idiopathic nephrotic syndrome.

Clinical nephrology·1997
Same author

Atypical hemolytic-uremic syndrome: a comparison with postdiarrheal disease.

The Journal of pediatrics·1996
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Area of Science:

  • Pediatrics
  • Nephrology
  • Infectious Diseases

Background:

  • Hemolytic uremic syndrome (HUS) is the primary cause of acute renal failure in young children.
  • Approximately 90% of HUS cases follow a diarrheal prodrome, predominantly linked to E. coli O157:H7 infections in the US.
  • Mortality from HUS is around 5%, with significant long-term renal damage in survivors.

Purpose of the Study:

  • To summarize the current understanding of HUS, focusing on postdiarrheal and idiopathic forms.
  • To highlight the impact of E. coli O157:H7 on HUS prevalence and outcomes.
  • To identify research priorities for developing effective intervention and treatment strategies.

Main Methods:

  • Review of existing evidence on HUS etiology, pathogenesis, and epidemiology.

Related Experiment Videos

  • Analysis of public health strategies aimed at reducing HUS incidence.
  • Identification of knowledge gaps in understanding HUS pathogenesis and idiopathic variants.

    • Main Results:

    • EHEC O157:H7 is the primary cause of postdiarrheal HUS, a major cause of pediatric acute kidney injury.
    • Public health initiatives like improved food safety practices are effective in decreasing HUS prevalence.
    • Significant percentages of HUS survivors experience chronic renal damage, necessitating further research.

    Conclusions:

    • Continued research into the pathogenic cascade of postdiarrheal HUS and development of animal models are crucial for effective interventions.
    • Preventing severe extrarenal complications, particularly CNS involvement, remains a significant clinical challenge.
    • Further investigation into the poorly understood idiopathic, non-diarrheal HUS variants is a research priority.